Infectious Diseases

Diagnostic test products have never been more critical. Kalorama Information’s report, 2021 IVD Market Update and COVID-19 Impact, provides an updated analysis of the in vitro diagnostics (IVD) market, reflecting the latest information from our analysts. This comprehensive report includes market sizing for various IVD categories and examines the major trends and impacts of COVID-19…

In vitro diagnostic (IVD) test volumes are crucial for assessing market opportunities for new entrants with diagnostic products and beneficial for existing product marketers. Kalorama’s In Vitro Diagnostic (IVD) Procedure Volumes, 2020-2025 delivers comprehensive market analysis, saving time with detailed calculations and estimates for the current and future number of diagnostic tests across multiple categories.…

The global COVID-19 pandemic has profoundly transformed the diagnostic industry, creating an unprecedented demand for test products and leading to significant market growth. Kalorama Information’s COVID-19 Testing Update, 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends report offers an in-depth analysis of this rapidly evolving market, focusing on molecular, antigen, and…

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2nd Edition provides a comprehensive analysis of the global sequencing market. This report covers market trends, challenges, strategies, and detailed profiles of key companies and products. It includes precise market share estimates and revenue growth forecasts, offering insights into the competitive landscape, including major deals and product developments.…

Companion diagnostics are revolutionizing pharmaceutical development and treatment, particularly in oncology. By identifying patients with specific biomarkers or disease-specific therapeutic targets, companion diagnostics significantly improve clinical success rates and patient outcomes. They also reduce costs by pinpointing the patient population most likely to benefit from a therapy and excluding those for whom the therapy would…

This report provides an insightful update on the global in vitro diagnostics (IVD) market, analyzing various factors shaping its current landscape. Covering a span from 2019 to 2024, key topics include:

• Market Developments in Key Regions: North America, EU15/Western Europe, Eastern Europe, Japan, and China
• Examination of Genetic Testing Trends
• Insights into New Point-of-Care…

Biomarkers are biological or biochemical molecules, genetic changes, or other measurable characteristics that indicate or predict a condition, risk, or likely biological response. They have a wide range of diagnostic applications, including predicting disease risk, diagnosis, prognosis, identifying appropriate therapy, and monitoring disease or its recurrence.

Kalorama Information’s World Market for Biomarkers (Cardiac [cTn, HscTn,…

In the healthcare system, reducing costs, saving sample volume, cutting down provider time, and improving outcomes are crucial goals. Syndromic multiplex diagnostic panels are emerging as a key solution to meet these objectives. These innovative tests can identify multiple pathogens from a single clinical specimen, transforming diagnostics by enabling faster, more accurate patient management, infection…

Sexually transmitted diseases (STDs) present a significant public health challenge, with approximately 550 million new cases worldwide each year, including over 35 million in the US alone. Kalorama Information’s latest report, Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics), offers an in-depth analysis of the global market for STD testing services and diagnostics from…